Comparison of patient-controlled analgesia with and without dexmedetomidine following spine surgery in children

Journal of Clinical Anesthesia

Volumn 21, Issue 7, 2009, Pages 493-501

  Sadhasivam, Senthilkumar ^a   Boat, Anne ^a   Mahmoud, Mohamed ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Dexmedetomidine, pain; Patient controlled analgesia; Pediatric anesthesia; Spine surgery

Indexed keywords

DEXMEDETOMIDINE; FENTANYL; HYDROMORPHONE; MORPHINE;

ADOLESCENT; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG USE; FEMALE; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; IDIOPATHIC SCOLIOSIS; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SCOLIOSIS; NEUROPATHIC PAIN; PATIENT CONTROLLED ANALGESIA; PERIOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SPINE SURGERY; STRATIFICATION; TREATMENT OUTCOME;

ADOLESCENT; ANALGESIA, PATIENT-CONTROLLED; ANESTHESIA, INTRAVENOUS; DEXMEDETOMIDINE; FEMALE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; INFUSIONS, INTRAVENOUS; INTENSIVE CARE; LENGTH OF STAY; MALE; MULTIVARIATE ANALYSIS; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE NAUSEA AND VOMITING; RESPIRATORY INSUFFICIENCY; SCOLIOSIS; SPINE; TREATMENT OUTCOME;

EID: 71649100529     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinane.2008.12.017     Document Type: Article

References (24)

1. Virtanen R., Savola J.M., Saano V., and Nyman L. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist. Eur J Pharmacol 150 (1988) 9-14
2. Tobias J.D. Dexmedetomidine: applications in pediatric critical care and pediatric anesthesiology. Pediatr Crit Care Med 8 (2007) 115-131
3. Ebert T.J., Hall J.E., Barney J.A., Uhrich T.D., and Colinco M.D. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 93 (2000) 382-394
4. Jaakola M.L., Salonen M., Lehtinen R., and Scheinin H. The analgesic action of dexmedetomidine-a novel alpha 2-adrenoceptor agonist-in healthy volunteers. Pain 46 (1991) 281-285
5. Aho M.S., Erkola O.A., Scheinin H., Lehtinen A.M., and Korttila K.T. Effect of intravenously administered dexmedetomidine on pain after laparoscopic tubal ligation. Anesth Analg 73 (1991) 112-118
6. Arain S.R., Ruehlow R.M., Uhrich T.D., and Ebert T.J. The efficacy of dexmedetomidine versus morphine for postoperative analgesia after major inpatient surgery. Anesth Analg 98 (2004) 153-158
7. Venn R.M., Hell J., and Grounds R.M. Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 4 (2000) 302-308
8. Bloor B.C., Ward D.S., Belleville J.P., and Maze M. Effects of intravenous dexmedetomidine in humans. II. Hemodynamic changes. Anesthesiology 77 (1992) 1134-1142
9. Deutsch E., and Tobias J.D. Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia: sevoflurane vs desflurane. Paediatr Anaesth 17 (2007) 438-444
10. Mahmoud M., Sadhasivam S., Sestokas A.K., Samuels P., and McAuliffe J. Loss of transcranial electric motor evoked potentials during pediatric spine surgery with dexmedetomidine. Anesthesiology 106 (2007) 393-396
11. Wewers M.E., and Lowe N.K. A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health 13 (1990) 227-236
12. Correa-Sales C., Rabin B.C., and Maze M. A hypnotic response to dexmedetomidine, an alpha 2 agonist, is mediated in the locus coeruleus in rats. Anesthesiology 76 (1992) 948-952
13. Nelson L.E., Lu J., Guo T., Saper C.B., Franks N.P., and Maze M. The alpha2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 98 (2003) 428-436
14. Wandel C., Witte J.S., Hall J.M., Stein C.M., Wood A.J., and Wilkinson G.R. CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5′-promoter region polymorphism. Clin Pharmacol Ther 68 (2000) 82-91
15. Belleville J.P., Ward D.S., Bloor B.C., and Maze M. Effects of intravenous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate. Anesthesiology 77 (1992) 1125-1133
16. Chrysostomou C., Di Filippo S., Manrique A.M., et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 7 (2006) 126-131
17. Tobias J.D., and Berkenbosch J.W. Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 12 (2002) 171-175
18. Jolkkonen J., Puurunen K., Koistinaho J., et al. Neuroprotection by the alpha2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur J Pharmacol 372 (1999) 31-36
19. Li B.H., Lohmann J.S., Schuler H.G., and Cronin A.J. Preservation of the cortical somatosensory-evoked potential during dexmedetomidine infusion in rats. Anesth Analg 96 (2003) 1155-1160
20. Peden C.J., Cloote A.H., Stratford N., and Prys-Roberts C. The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia 56 (2001) 408-413
21. Ingersoll-Weng E., Manecke Jr. G.R., and Thistlethwaite P.A. Dexmedetomidine and cardiac arrest. Anesthesiology 100 (2004) 738-739
22. Ho A.M., Chen S., and Karmakar M.K. Central apnoea after balanced general anaesthesia that included dexmedetomidine. Br J Anaesth 95 (2005) 773-775
23. Tobias J.D., and Berkenbosch J.W. Sedation during mechanical ventilation in infants and children: dexmedetomidine versus midazolam. South Med J 97 (2004) 451-455
24. Rosen D.A., and Daume J.T. Short duration large dose dexmedetomidine in a pediatric patient during procedural sedation. Anesth Analg 103 (2006) 68-69